Ontrial: AI-driven and EMR integrated clinical trial recruitment tool used by clinical trial and provider teams for recruitment of diverse populations.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91024C00060
- Awardee
-
Vizlitics Inc. UEI N1EMHHVX3F35
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,049,966
Award facts
- Contract value 100% obligated
- $2,049,966.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10010, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,049,966 |
About this award
The National Cancer Institute (NCI), a civilian government agency, awarded a $2,049,966 firm fixed-price definitive contract to Vizlitics Inc., a small business, for the development of ONTRIAL - an AI-driven and EMR-integrated clinical trial recruitment tool. The contract, which is set aside for small businesses, has an ultimate completion date of September 15, 2026. ONTRIAL is designed to assist clinical trial and provider teams in recruiting diverse patient populations, addressing a critical need in medical research. Vizlitics has also secured several federal grants from the NCI to support its efforts in advancing cancer care through innovative technology solutions, including the development of VIPCARE, a cloud-based software-as-a-service platform to improve follow-up care for prostate cancer patients, and ONCOPATH, an intelligent clinical pathway decision support tool for non-small cell lung cancer treatment.
Quick answers
Who was awarded contract 75N91024C00060?
75N91024C00060 was awarded to Vizlitics Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2024.
How much is contract 75N91024C00060 worth?
The government has obligated $2,049,966 on 75N91024C00060.
Was contract 75N91024C00060 competed?
The extent of competition for 75N91024C00060 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award